Approaches to treatment of type 2 diabetes

被引：13
作者：
Bloomgarden, Zachary T. [1 ]
机构：
[1] Mt Sinai Sch Med, Div Endocrinol, New York, NY USA
来源：
DIABETES CARE | 2008年 / 31卷 / 08期
关键词：
D O I：
10.2337/dc08-zb08
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1697 / 1703
页数：7
相关论文
共 50 条
[41]   Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients [J].
Rosenstock, J ;
Sugimoto, D ;
Strange, P ;
Stewart, JA ;
Soltes-Rak, E ;
Dailey, G .
DIABETES CARE, 2006, 29 (03) :554-559
[42]   Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study [J].
Rosenstock, Julio ;
Brazg, Ronald ;
Andryuk, Paula J. ;
Lu, Kaifeng ;
Stein, Peter .
CLINICAL THERAPEUTICS, 2006, 28 (10) :1556-1568
[43]   Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus [J].
Sidhu, JS ;
Kaposzta, Z ;
Markus, HS ;
Kaski, JC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :930-934
[44]   Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM - Results of two multicenter, randomized, placebo-controlled clinical trials [J].
Simonson, DC ;
Kourides, IA ;
Feinglos, M ;
Shamoon, H ;
Fischette, CT ;
Aronoff, S ;
Blonde, L ;
Cefalu, W ;
Clement, S ;
Greenberg, C ;
Levin, S ;
Lucas, CP ;
Macy, C ;
Manning, J ;
Marbury, TC ;
McAdams, MJ ;
Mezitis, NHE ;
Miller, S ;
Owens, D ;
Sandler, J ;
Schwartz, SL ;
Shamoon, H ;
Sosenko, J .
DIABETES CARE, 1997, 20 (04) :597-606
[45]   Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study [J].
Stratton, IM ;
Adler, AI ;
Neil, HAW ;
Matthews, DR ;
Manley, SE ;
Cull, CA ;
Hadden, D ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :405-412
[46]   Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3 [J].
Tuomi, T ;
Sarelin, L ;
Honkanen, EH ;
Groop, LC ;
Isomaa, B .
DIABETES CARE, 2006, 29 (02) :189-194
[47]   Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].
Turner, RC ;
Holman, RR ;
Stratton, IM ;
Cull, CA ;
Matthews, DR ;
Manley, SE ;
Frighi, V ;
Wright, D ;
Neil, A ;
Kohner, E ;
McElroy, H ;
Fox, C ;
Hadden, D .
LANCET, 1998, 352 (9131) :854-865
[48]   Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49) [J].
Turner, RC ;
Cull, CA ;
Frighi, V ;
Holman, RR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (21) :2005-2012
[49]   Effect of pioglitazone on pancreatic β-cell function and diabetes risk in Hispanic women with prior gestational diabetes [J].
Xiang, AH ;
Peters, RK ;
Kjos, SL ;
Marroquin, A ;
Goico, J ;
Ochoa, C ;
Kawakubo, M ;
Buchanan, TA .
DIABETES, 2006, 55 (02) :517-522
[50]   Drug therapy: Thiazolidinediones [J].
Yki-Jarvinen, H .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) :1106-1118
12345